Filing Details
- Accession Number:
- 0001140361-16-071993
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-08 14:14:48
- Reporting Period:
- 2016-07-05
- Filing Date:
- 2016-07-08
- Accepted Time:
- 2016-07-08 14:14:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1335103 | Protea Biosciences Group Inc. | PRGB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529510 | C Stephen Turner | 1311 Pineview Drive Suite 501 Morgantown WV 26505 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-05 | 24,000 | $0.15 | 2,177,372 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote 1 to this Form 4.
Billionaire Hedge Funds
